1. Introduction {#s0005}
===============

During growth period, shaft bones such as limb have two cartilage tissue, articular cartilage and epiphyseal cartilage ([@bb0185]). Both cartilage has distinct function, articular cartilage exhibits ablation resistance and epiphyseal cartilage plays a role as a growth center ([@bb0075], [@bb0055]). However, mandibular condylar cartilage (MCC) plays dual roles, both articular cartilage and growth center ([@bb0040]).

Cartilage formation in MCC and subsequent osteogenesis are regulated by many soluble factors such as IGF-1 ([@bb0125]), TGF-β ([@bb0080]), BMP ([@bb0025]), Ihh ([@bb0030]), and Shh ([@bb0140]). TGF-β, one of the most abundant cytokines in the bone matrix ([@bb0015]), has been proven to play a central role in bone remodeling by regulating migration, proliferation, and differentiation of osteoprogenitors ([@bb0090], [@bb0180], [@bb0085]). In addition, TGF-β has been associated with the development and maintenance of articular cartilage ([@bb0135]), and may regulate condylar cartilage proliferation, differentiation ([@bb0115], [@bb0065]), and development ([@bb0155]).

Asporin, a novel member of the leucine-rich repeat family of proteins ([@bb0205]), is expressed in a variety of mouse ([@bb0060]) and human tissues including osteoarthritic articular cartilage with higher levels ([@bb0120]). A significant association between a polymorphism in the aspartic acid repeat of the gene encoding Asporin and osteoarthritis was reported ([@bb0105]). In this report, a direct interaction between Asporin and TGF-β, in other word, Asporin neutralizes the function of TGF-β, was also reported. Furthermore, Asporin blocks chondrogenesis and inhibits TGF-β-induced expression of chondrocyte phenotypes ([@bb0145], [@bb0110]).

To date, there is no report about the expression of Asporin in MCC nor the relation to endochondral growth of mandible. In the present study, we investigated the temporal and spatial expression of Asporin in MCC to clarify the role of Asporin in the regulation of endochondral growth of MCC using mice.

2. Materials and methods {#s0010}
========================

2.1. Animals {#s0015}
------------

Male ICR mice (1, 3, 5, 10 and 20-week(s)-old; (*n* = 4): CLEA Japan, Inc. Tokyo Japan) were used for this study. All procedures were approved by Animal Research Committee of Tsurumi University (approved numbers: 24P065, 25P013, 26P074, and 27P070). All animal research is reported in accordance with ARRIVE guidelines.

2.2. Tissue preparation {#s0020}
-----------------------

Mice were sacrificed by cervical dislocation. Mandible and tibia were immediately excised, and the specimen were embedded in OCT compound (Sakura Fineteck Japan, Tokyo, Japan) and rapidly frozen in isopentane cooled by liquid nitrogen. Undecalcified nonfixed serial frozen sections (5 μm-thick) were prepared using a super-hard tungsten steel knife (Meiwa Shoji Ltd., Tokyo, Japan) in − 25 °C cryostat (Leica Microsystems, Wetzlar, Germany) ([@bb0150]). The sections were collected individually on a 1.35 μm thick polyethylene naphthalene membrane with an adhesive (SECTION-LAB Ltd., Hiroshima, Japan) ([@bb0095]) and stuck onto slides. Then the sections were slightly fixed with nuclease-free 95% and 75% ethanol for 30--40 s. each, and 50% for 25--30 s. Next, they were stained with Cresyl Violet which provided as LCM Staining Kit (Ambion, Austin, TX) for 40 s., and they were washed through nuclease-free 50% and 75% ethanol for 25--30 s. each, and 95% and 100% for 30--40 s. each.

2.3. Laser capture microdissection {#s0025}
----------------------------------

Each layers of MCC, tibial epiphyseal cartilage were microdissected and collected using laser capture microdissection (P.A.L.M. Microlaser Technologies, Bernried, Germany). Mandibular condylar cartilage and tibial growth plate were divided into three layers; mandibular fibrous layer (MF), mandibular proliferating layer (MP), mandibular hypertrophic layer (MH), tibial reserve layer (TR), tibial proliferating layer (TP), and tibial hypertrophic layer (TH), respectively ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1Laser capture microdissection of cartilage tissue.Representative images of mandibular condyle of 5w ICR mouse (*n* = 4) in lower magnification (A) and higher magnification (B). MF: mandibular fibrous layer. MP: mandibular proliferating layer. MH: mandibular hypertrophic layer. Representative images of tibial mesial condyle of 5w ICR mouse (*n* = 4) in lower magnification (C) and higher magnification (D). TR: tibial reserve layer. TP: tibial proliferating layer. TH: tibial hypertrophic layer. Representative image of after microdissection at MF (E). Bar: 100 μm.Fig. 1

Pooled microdissected cartilage tissues (5 sections, approximately 140 μm^2^) were used for RNA extraction.

2.4. Extraction of total RNA {#s0030}
----------------------------

Total RNAs were extracted using RNeasy Micro Kit (QIAGEN, Hilden, Germany) with complete removal of residual genomic DNA through RNase-free DNase I (QIAGEN, Hilden, Germany) treatment according to the manufacture\'s protocol.

2.5. Microarray analysis {#s0035}
------------------------

RNA samples of MF and TR from 5-weeks-old mice were collected, and were analyzed by Whole Mouse Genome Microarray 4x44K (Agilent Technologies, Santa Clara, CA). Whole gene expression levels in CF were relatively compared to that in TR, and sorted with expression ratio.

2.6. Reverse transcription and Real-time RT PCR {#s0040}
-----------------------------------------------

cDNA was synthesized using iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad Laboratories, CA) and was diluted (× 2) with Tris-EDTA buffer. Real-time RT-PCR was performed with SsoFast EvaGreen Supermix (Bio-Rad Laboratories) with the following oligonucleotide primers: Asporin (accession number: NM_025711), Forward: GGGAGTGAATGACTTCTGTC, Reverse: ACTCATTCTGCCAAGAACAC; TGF-β1 (accession number: NM_011577), Forward: CTCCCGTGGCTTCTAGTGC, Reverse: GCCTTAGTTTGGACAGGATCTG; GAPDH (accession number: NM_008085), forward: ACTTTGTCAAGCTCATTTCC, reverse: GTGAGGGGAGGAGTCTCAA. Fold changes of gene of interest were calculated with ΔΔCt method using GAPDH as reference gene.

2.7. Immunohistochemistry {#s0045}
-------------------------

Briefly, undecalcified nonfixed serial frozen sections were fixed in 100% ethanol for 1 min, incubated in 3% H~2~O~2~ to quench endogenous peroxidase activity for 30 min, and then blocked with normal goat serum for 1 h at room temperature. The sections were then incubated with primary antibody diluted 1:500 with 1.5% goat serum in PBS overnight at 4 °C. The primary antibodies we used were as follows; anti Asporin antibody (Acris, San Diego, CA), anti p-Smad2/3 antibody (Santa Cruz Biotechnology, Santa Cruz, CA), and anti TGF-β antibody (Cusabio, Collage Park, MD). After wash, biotinylated secondary antibody followed by avidin-horseradish peroxidase reactions (goat ABC staining system, Santa Cruz Biotechnology, CA) was performed. Color development was obtained using diaminobenzidine (DAB) for 2 min, and they were observed by a microscope (BZ9000; KEYENCE, Osaka, Japan).

2.8. Immuno-fluorescent staining {#s0050}
--------------------------------

Undecalcified nonfixed serial frozen sections were fixed in 100% ethanol for 1 min and blocked with Block ACE (DS farma biomedical, Saitama, Japan) for 10 min at room temperature. The sections were then incubated with primary antibody diluted 1:500 with Antibody Diluent Solution (Invitrogen, Carlsbad, CA) for 2 h at 4 °C. The primary antibodies we used were as follows; rabbit IgG anti Asporin antibody (Acris) and mouse IgG anti TGF-β antibody (R&D SYSTEMS, Minneapolis, Minnesota). After wash, the sections were then incubated with secondary antibody diluted 1:3000 with Antibody Diluent Solution for 2 h at 4 °C. The secondary antibodies we used were as follows; Alexa 568-conjugated anti rabbit IgG antibody (Thermo Fisher Scientific, Kanagawa, Japan) for anti Asporin antibody and DyLight 488-conjugated anti mouse IgG antibody (Merck, Darmstadt, Germany) for anti TGF-β antibody.

2.9. Statistical analysis {#s0055}
-------------------------

The groups were compared using non-paired Student *t*-test. The multigroup of each layers and time points was compared using Tukey tests. *p* \< 0.05 was considered statistically significant.

3. Results {#s0060}
==========

3.1. Gene expression analysis in MCC {#s0065}
------------------------------------

First of all, we compared gene expression between MF layer in MCC and TR in tibia at 5-weeks old. [Table 1](#t0005){ref-type="table"} shows the top 30 gene probes which exhibited high expression ratio in MF as compared to those of TR in tibia. Dual oxidase maturation factor 1 (NM_145395) was the highest induced gene in MF layer of MCC, followed by LIM homeobox protein 8 (NM_010713), Goosecoid (NM_010351), Semaphorin 3E (NM_011348), and Angiopoietin-like 1 (NM_028333). Of interest, osteoarthritis-related gene, Asporin, was 293-fold expression in MF layer of MCC. TGF-βs, BMPs, Ihh, and Shh exhibited almost stable gene expression within 3-fold change (data not shown).Table 1Upregulated gene in MF as compared to TR by microarray.Table 1Gene nameDescriptionAccession no.Expression levelsFold changeMFTR1Duoxa1Dual oxidase maturation factor 1NM_14539521,106.94.84366.82Lhx8LIM homeobox protein 8NM_01071314,481.84.63154.63GscGoosecoidNM_01035113,625.45.32577.34Sema3eSema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3ENM_0113486667.04.51466.35Angptl1Angiopoietin-like 1NM_0283336751.54.81410.46Dlx2Distal-less homeobox 2NM_0100545038.25.5924.27Creb5CAMP responsive element binding protein 5NM_1727285445.46.1891.385830417I10 RikRIKEN cDNA 5830417I10 geneAY0408424044.14.8845.39Duox1Dual oxidase 1XM_13048310,431.418.2573.410Wnt10aWingless related MMTV integration site 10aNM_0095182475.84.7525.211Duox1Dual oxidase 1XM_13048310,235.420.4500.512Duox1Dual oxidase 1XM_13048310,436.621.9476.013Duox1Dual oxidase 1XM_1304839701.320.9464.014Duox1Dual oxidase 1XM_13048310,264.122.8450.715Duox1Dual oxidase 1XM_13048310,239.322.9446.416Duox1Dual oxidase 1XM_13048310,185.322.8446.217KeraKeratocanNM_0084382166.24.9440.118PtgesProstaglandin E synthaseNM_02241511,840.527.5430.719Duox1Dual oxidase 1XM_13048310,194.025.7396.220Duox1Dual oxidase 1XM_1304839779.724.8394.821Masp1Mannan-binding lectin serine peptidase 1AK0315982172.55.5393.622Casp3Caspase 3NM_0098109965.026.7373.0235830417I10 RikRIKEN cDNA 5830417I10 geneXM_0010009611684.55.0338.124Nr2f2Nuclear receptor subfamily 2, group F, member 2× 766531754.55.3328.525TnnTenascin NNM_17783927,913.085.9325.0269530026P05 RikRIKEN cDNA 9530026P05 geneAK0205761461.84.9295.527AspnAsporinNM_0257111624.35.5293.128D430019H16 RikRIKEN cDNA D430019H16 geneBC0586771314.34.8275.929DptDermatopontinNM_0197591279.04.6275.930EfhbEF hand domain family, member BNM_1724971336.54.9272.1

3.2. Asporin mRNA is extensively expressed in MCC as compared to tibial growth cartilage {#s0070}
----------------------------------------------------------------------------------------

To confirm the upregulated Asporin expression in MCC obtained by microarray analysis, we performed real-time RT-PCR. Consisted with microarray analysis, surface layer of MCC (MF) exhibited robust Asporin expression as compared to the surface layer of tibia (TR) at 5 weeks ([Fig. 2](#f0010){ref-type="fig"}A). Not only surface layer of MCC, but also another layers of MCC expressed much higher Asporin gene expression as compared to tibia.Fig. 2Real-time RT-PCR analysis for Asporin expression.Asporin mRNA levels were analyzed using Real-time RT-PCR. (A) Comparison at 5 weeks-old (*n* = 4). (B) Temporal change at surface layer of tibia and mandibular condyle is shown (*n* = 4). ND: not detectable (C) Temporal and spatial change of tibia and mandibular condyle is shown (*n* = 4). ND: not determined NS: not significant difference between groups \*: *p* \< 0.05.Fig. 2

Then we examined temporal Asporin gene expression in the surface layer of MCC ([Fig. 2](#f0010){ref-type="fig"}B). MF exhibited higher Asporin gene expression as compared to tibia at all time point we examined.

To further analyse temporal and spatial Asporin gene expression in each layer of MCC, namely, mandibular fibrous layer (MF), mandibular proliferating layer (MP), and mandibular hypertrophic layer (MH), real-time RT-PCR were performed ([Fig. 2](#f0010){ref-type="fig"}C). Deeper layer of MCC, MP and MH, expressed no detectable Asporin at early stage, and then, Asporin expression was observed with age in deeper layer of MCC.

3.3. Asporin protein is extensively expressed in MCC as compared to tibial growth cartilage {#s0075}
-------------------------------------------------------------------------------------------

We next examined protein level expression of Asporin in MCC. Consistent with the results of real-time RT-PCR, MF exhibited intense Asporin expression as compared to tibia ([Fig. 3](#f0015){ref-type="fig"}). Augmented Asporin expression in MF was stable during experimental period ([Fig. 3](#f0015){ref-type="fig"}F--L). On the other hand, Asporin expression in the deeper layer of MCC was increased with age ([Fig. 3](#f0015){ref-type="fig"}M). Interestingly, MCC thickness was largest in 1 week old, and it gradually reduced with age.Fig. 3Immunohistochemical staining for Asporin.Representative images of temporal change of Asporin expression in tibia and MCC are shown. Tibial mesial condyle at 1 week-old in lower magnification (A) and negative control of no primary antibody (B). Tibial epiphyseal cartilage at 1, 3, 5 week(s)-old in higher magnification (C--E). Mandibular condyle at 1 week-old in lower magnification (F) and negative control of no primary antibody (G). Mandibular condylar cartilage at 1, 3, 5, 10, 20 week(s)-old in higher magnification (H--L).Signal intensity of immune-reactivity are shown (*n* = 3). The mean value from three images was calculated using ImageJ (M). PO: primary ossification center SO: secondary ossification center TR: Tibial reserve layer TP: tibial proliferating layer TH: tibial hypertrophic layer MF: mandibular fibrous layer MP: Mandibular proliferating layer MH: Mandibular hypertrophic layer ND: not detectable \*: *p* \< 0.05 bar: 50 μm.Fig. 3

As Asporin was reported to inhibit TGF-β signaling ([@bb0045]), these results suggest that augmented Asporin in MCC would negatively regulate TGF-β-mediated chondrogenesis.

3.4. TGF-β in MCC was relatively weak as compared to tibial growth cartilage {#s0080}
----------------------------------------------------------------------------

As it was reported that Asporin blocks chondrogenesis and inhibits TGF-β-induced expression of chondrocyte phenotypes ([@bb0145], [@bb0110]), we next examined the expression of TGF-β at 5 weeks-old by real-time RT-PCR ([Fig. 4](#f0020){ref-type="fig"}A). Each layers of MCC expressed TGF-β though the expression was weak as compared to that in tibia.Fig. 4Expression levels of TGF-β1 in tibia and MCC.Real-time RT-PCR for TGF-β1 (A). NS: Not significant difference among the groups. Immunohistochemical staining for TGF-β1.Representative images of 1 week (B, E), 3 weeks (C, F), 5 weeks (D, G), 10 weeks (H), 20 weeks (I) and negative control of no primary antibody (J) are shown. Signal intensity of immune-reactivity is shown (*n* = 3). The mean value from three images was calculated using ImageJ (K). ND: not detectable NS: not significant difference bar: 100 μm.Fig. 4

Then we examined protein level expression of TGF-β, and found that TGF-β1 expression was intense at both mandibular and tibial cartilage in the growing phase ([Fig. 4](#f0020){ref-type="fig"}B--G). It was decreased in MCC at 10 and 20 weeks old ([Fig. 4](#f0020){ref-type="fig"}H and I). The measurement of signal intensity clearly demonstrated that stable TGF-β expression was present until 5 weeks and then reduced with aging ([Fig. 4](#f0020){ref-type="fig"}K). These changes in Asporin and TGF-β expression suggest that TGF-β is neutralized after growth, and thereby TGF-β signaling would be relatively weak in adult.

3.5. Asporin and TGF-β1 were strongly co-localized on the fibrous layer of MCC {#s0085}
------------------------------------------------------------------------------

Immuno-fluorescent staining of Asporin and TGF-β were performed using the MCC of 3 weeks-old mice ([Fig. 5](#f0025){ref-type="fig"}). Consistent with [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}, Asporin (red: [Fig. 5](#f0025){ref-type="fig"}B) and TGF-β (green: [Fig. 5](#f0025){ref-type="fig"}C) were expressed in the fibrous layer of MCC. Merged image of the green and red fluorescence revealed that the co-localization between Asporin and TGF-β in the fibrous layer of MCC ([Fig. 5](#f0025){ref-type="fig"}D). These results suggest that the TGF-β binds to Asporin in the fibrous layer of MCC.Fig. 5Immuno-fluorescent staining of Asporin and TGF-β in MCC.Representative images of bright field (A), immuno-fluorescent staining of Asporin (B) and TGF-β (C), and merged image of green and red fluorescence (D) are shown (Panel D). Bar: 100 μm. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 5

3.6. TGF-β signaling is attenuated by augmented Asporin in MCC {#s0090}
--------------------------------------------------------------

Finally, we observed whether TGF-β signaling is attenuated by augmented Asporin in MCC with immunohistochemical staining for phosphorylated Smad-2/3 (p-Smad-2/3), which is one of the well-known signaling molecule after TGF receptor ([@bb0050]). Immuno-reactivity against p-Smad-2/3 was observed at the entire layers of tibial cartilage ([Fig. 6](#f0030){ref-type="fig"}A--C). In MCC, immuno-reactivity against p-Smad-2/3 was intense at deeper layers at 3 and 5 weeks old, while MF layer exhibited no immuno-reactivity against p-Smad-2/3 ([Fig. 6](#f0030){ref-type="fig"}E and F). p-Smad-2/3 in the deeper layers of MCC was gradually reduced with age ([Fig. 6](#f0030){ref-type="fig"}D--H). These results suggest that TGF-β signaling is suppressed by augmented Asporin and decreased TGF-β production in MCC.Fig. 6Immunohistochemical staining for p-Smad2/3.Representative images of Tibia (Panels A--C), MCC (Panels D--H), and negative control of no primary antibody (I) are shown. Signal intensity of immune-reactivity is shown (*n* = 3). The mean value from three images was calculated using ImageJ (J). ND: not detectable NS: not significant difference bar: 100 μm.Fig. 6

4. Discussion {#s0095}
=============

In the present study, we discovered that Asporin, inhibitor of TGF-β signaling ([@bb0200]), was expressed in MCC. Asporin was stably expressed at the fibrous layer of MCC at any time points, and the deeper layer of MCC exhibited the gradual augmentation of Asporin with age. To our knowledge, this is the first report which describes temporal and spatial change of Asporin expression in MCC.

Microarray analysis demonstrated the different gene expression pattern between MCC and growth plate of tibia. Asporin was highly expressed in MCC. On the other hand, tibial epiphyseal cartilage exhibited faint Asporin expression, which was consistent with the previous study. These results indicate that MCC is different from the other growth cartilage in the expression of Asporin. Besides Asporin, some genes related to the bone metabolism were upregulated. Among them, Sema3e inhibits osteoblast migration and decrease osteoclast formation ([@bb0070]). Tenascin-N was reported to inhibit proliferation and differentiation of preosteoblasts during endochondral bone formation ([@bb0100]). These also indicate that MCC is different from the other growth cartilage. Further investigation is necessary to clarify the relationship between these unique gene expression and tissue specificity of MCC.

Asporin binds to TGF-β and consequently inhibits the binding of TGF-β to the receptor, which results in the suppression of TGF-β signaling ([@bb0145]). Nakajima also reported that Asporin has putative binding sites to TGF-β; peptide 159--205 (P159--205), P33--373, P33--167, P48--167 and P279--373. Although each site differs in its binding ability, all of them can impede the dimerization of TGF-β RII to affect the stability of the TGF-β RI and RII complexes, thus hindering TGF-β induced chondrogenesis ([@bb0145]).

When TGF-β1 binds to its receptor, cytoplasmic Smads, such as Smad-2 and Smad-3 are phosphorylated, which results in the activation of intercellular signal of TGF-β ([@bb0050]). The results in immunohistochemistry revealed that Asporin and TGF-β were strongly co-localized in the fibrous layer of MCC. Furthermore, the immunohistochemistry of p-Smad-2/3 clearly revealed that TGF-β signaling was attenuated in the MF layer where Asporin was highly expressed, as compared to the epiphyseal cartilage in tibia. These indicate that Asporin in MF layer binds to TGF-β and inhibits TGF-β signaling in MF layer.

MCC is classified as a secondary cartilage ([@bb0175]) and is structurally fibrocartilages which is different from both the limb growth plate and the other articular cartilage ([@bb0170]). The surface fibrous layer composes a perichondrium in which the cells are relatively undifferentiated and produce type I collagen rather than type II collagen ([@bb0165], [@bb0130]). MCC was thick in the developing stage, though the thickness gradually reduced with age (at 10 and 20 weeks old). In addition, fibrocartilage cells in the condylar cartilage secrete various kind of cytokines which regulates chondrocyte proliferation and differentiation ([@bb0130], [@bb0190]). Among them, TGF-β is one of important promotors of chondrocyte proliferation and differentiation ([@bb0195]). Robust Asporin expression in the fibrous layer of condylar cartilage in this study negatively regulates TGF-β-mediated chondrocyte proliferation and differentiation during growing stage. In this context, Asporin expression in the fibrous layer maintains the function of MCC as the fibrocartilage through the negative regulation of TGF-β.

The high expression of Asporin expands from the surface fibrous layer to the deeper layers of MCC with age, signifying TGF-β signaling is gradually suppressed in the deeper layer of MCC with age. This augmented Asporin in the deeper layers in the aged mice inhibits chondrocyte differentiation and transition to bone formation with age and fine-tune TGF-β-mediated condylar morphogenesis, which consequently regulates the mandibular growth.

On the other hand, a long-term presence of Asporin keeps the cells in undifferentiated state and might reduce the capacity for the adaptation to temporomandibular disorder.

Orthodontic treatment applies mechanical stress on MCC for the control of endochondral growth ([@bb0010]), though cartilage tissue in MCC is thought to have resistance to mechanical stress ([@bb0035], [@bb0020]). Difference in Asporin expression between MCC and tibia would give the interpretation of the difference in mechano-resistance. Further investigation is necessary to clarify whether mechanical stress changes the expression of Asporin in MCC.

Recently, Asporin expression is considered to be one of the major factors for osteoarthritis. Asporin intensity was significantly associated with the severity of cartilage degeneration in the study on Asporin expression in the knee osteoarthritis patients and the healthy ([@bb0160]). Osteoarthritis in MCC is high prevalence in the elderly, which results in the deformation of mandibular condyle as compared to young people ([@bb0005]). Considering the high expression of Asporin in MCC, the long-term presence of Asporin in the MCC might attenuate the protective mechanism against the condylar degeneration. Further study will be necessary to investigate the relationship between Asporin and osteoarthritis in MCC.

5. Conclusion {#s0100}
=============

We discovered that Asporin was expressed in MCC, which controls dual roles of articular cartilage and growth center through regulation of TGF-β signaling.
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